ArticleNPJ Parkinson's disease2025
Effect of high, low, and asymmetric frequency subthalamic stimulation on speech and voice in Parkinson's disease: a randomized trial.
Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
While bilateral high-frequency subthalamic nucleus stimulation (Bi-HFS) frequently worsens speech in Parkinson's disease (PD), low-frequency stimulation (LFS) may alleviate gait deficits but lacks robust evidence for speech benefits. This randomized trial compared Bi-LFS (60 Hz) and Bi-HFS (130 Hz) in 33 PD patients with postural instability/gait difficulty (PIGD), and evaluated asymmetric frequency stimulation (AFS) in 20 patients. Bi-LFS significantly improved dysphonia severity index (DSI, FDR-p = 0.024), maximum phonation time (MPT, FDR- p = 0.025), and subjective speech ratings compared to Bi-HFS. Left-LFS/right-HFS (L-LFS/R-HFS) matched Bi-LFS efficacy and surpassed Bi-HFS in objective measures (FDR-p ≤ 0.021). Speech improvements correlated with motor/gait gains, independent of tremor. Findings suggest Bi-LFS mitigates speech dysfunction in PIGD-PD, with left-sided LFS potentially driving benefits, while AFS provides comparable outcomes. These data support tailored stimulation protocols to optimize speech in PD. The National Medical Research Registration and Information System of China (MR-31-23-036810).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.